Skip to main content

RB Capital Management, LLC

Position in SGMT — Sagimet Biosciences Inc.

CIK 1695582 RENO, NV

Position in SGMT

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$749,810
+$242,985 QoQ
Shares Held
97,000
0.0% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#50
of 122 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 40% Shared 0% None 60%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Derivatives in SGMT

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$473,600
PutShares
80,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RB Capital Management, LLC holds $1,137,224 across 3 Biotechnology names. SGMT ranks #1 (65.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SGMT
Sagimet Biosciences Inc.
This page
97,000 $749,810

All Filings in SGMT

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $749,810 97,000
2026-03-31 $506,825 97,000
2025-12-31 $473,600 80,000
2025-12-31 $574,240 97,000